Cambridge (UK), 1 June 2004. Biotechnology Management Practices, a new 2-volume report based on data collected from 200 biotech senior managers at over 75 companies, looks set to provide executives, investors and VCs with a valuable insight into the operating models of the most successful biotech companies.

Compiled by industry experts Mardis Aibel & Associates (New York) and available in Europe exclusively through Biotech consulting specialists Progenta LLP (Cambridge, UK), Biotechnology Management Practices provides a comprehensive guide to best-practice across the spectrum of business functions.

John Cassells and Richard Philpott of Progenta, Mardis Aibel’s European partners, commented:

“On offer for the first time is an in depth study and practical roadmap for everyone in Biotech and associated life science industries. Biotech Management Practices contains compelling data on how top organisations make things work, and stresses the need to strengthen management skills and practises. At the core of the report is a Biotechnology Management Lifecycle Model that accurately documents the management challenges a company faces as it makes the transition from start-up through development to commercialisation.

The views of Biotech Industry executives on the real challenges they face and how they are overcoming them are presented along with independent candid advice from top investors, executive recruiters, and communication experts.

For more details, visit www.progenta.co.uk

Landmark new study benchmarks biotech management for the first time…/2

A photograph of the new Biotechnology Management Practices report is available as a digital file sent with this press release, or to request the file, please contact Richard Kent at Kapler Communications richard@kapleronline.com , quoting PRG/PRL/001

About Progenta:

Founded by life science business specialists Dr John Cassells and Dr Richard Philpott, Progenta LLP, Cambridge, UK (www.progenta.co.uk) focuses on making businesses out of technology and improving the performance of technology-based companies. They support investors and companies in life science, biotechnology and related sectors with all aspects of business strategy, execution, rationalisation, development and commercialisation. They specialise in giving pragmatic commercially founded advice combined with operational involvement.

About Mardis Aibel:

Mardis, Aibel & Associates, LLC (www.mardisaibel.com) are based in New York and provide consulting, information, advice and professional development to biotechnology executives, industry investors and affiliated companies. They provide industry insights, help you to arrive at a decision and drive your implementation plan.

Contact details:

Press enquiries – Richard Kent, Kapler Communications Ltd.

Tel: +44 (0)1480 471117 email: richard@kapleronline.com

 www.kapleronline.com

Further details and business enquiries – Richard Philpott, Progenta LLP,

Beech House, Church Lane, Elsworth, Cambridge, CB3 8HU, UK 

Tel: +44(0)1954 267379 email: rphilpott@progenta.co.uk